Clinical Trial Update: HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC [Phase 3]

View source ↗

Summary

Phase 3 trial comparing hepatic arterial infusion chemotherapy with FOLFOX to systemic GP chemotherapy for unresectable intrahepatic cholangiocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• FOLFOX-HAIC
• GP (gemcitabine and cisplatin)

Snippet

Sponsor: Shi Ming | Conditions: Intrahepatic Cholangiocarcinoma | Phase 3 | Status: UNKNOWN